EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Thymoma‐associated autoimmune encephalitis with myasthenia gravis: Case series and literature review

Miao Su, Qiuyan Luo iD, Zichao Wu, Huiyu Feng iD, Hongyan Zhou iD

CNS Neuroscience & Therapeutics · 2024-02 · 30 (2)

DOI: 10.1111/cns.14568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 07.02.2024. Verfasst von Miao Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms, Myasthenia Gravis, Encephalitis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This comprehensive review aimed to compile cases of patients with thymoma diagnosed with both autoimmune encephalitis (AE) and myasthenia gravis (MG), and describe their clinical characteristics.

Methods

Clinical records of 3 AE patients in the first affiliated hospital of Sun Yat‐sen University were reviewed. All of them were diagnosed with AE between 1 November 2021 and 1 March 2022, and clinical evidence about thymoma and MG was found. All published case reports were searched for comprehensive literature from January 1990 to June 2022.

Results

A total of 18 cases diagnosed with thymoma‐associated autoimmune encephalitis (TAAE) and thymoma‐associated myasthenia gravis (TAMG) were included in this complication, wherein 3 cases were in the first affiliated hospital of Sun Yat‐sen University and the other 15 were published case reports. 5/18 patients had alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antibody (AMPAR‐Ab) in their serum and cerebrospinal fluid (CSF). All of them had positive anti‐acetylcholine receptor antibody (AChR‐Ab). And 12/18 patients showed a positive response to thymectomy and immunotherapy. Besides, thymoma recurrences were detected because of AE onset. And the shortest interval between operation and AE onset was 2 years in patients with thymoma recurrence.

Conclusions

There was no significant difference in the clinical manifestations between these patients and others with only TAMG or TAAE. TAAE was commonly associated with AMPAR2‐Ab. Significantly, AE more commonly heralded thymoma recurrences than MG onset. And the intervals of thymectomy and MG or AE onset had different meanings for thymoma recurrence and prognoses of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaThymus NeoplasmsMyasthenia GravisEncephalitisHashimoto DiseaseHumans

Stichwörter der Autor:innen

autoimmune encephalitismyasthenia gravisthymectomythymoma

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou, China.

ORCID-Profile: Qiuyan Luo, Huiyu Feng, Hongyan Zhou

Zitieren

APA

Su, M., Luo, Q., Wu, Z., Feng, H., & Zhou, H. (2024). Thymoma‐associated autoimmune encephalitis with myasthenia gravis: Case series and literature review. CNS Neuroscience & Therapeutics, 30(2). https://doi.org/10.1111/cns.14568

Vancouver

Su M, Luo Q, Wu Z, Feng H, Zhou H. Thymoma‐associated autoimmune encephalitis with myasthenia gravis: Case series and literature review. CNS Neuroscience & Therapeutics. 2024;30(2). doi:10.1111/cns.14568

BibTeX
@article{Su2024,
  author = {Su, Miao and Luo, Qiuyan and Wu, Zichao and Feng, Huiyu and Zhou, Hongyan},
  title = {Thymoma‐associated autoimmune encephalitis with myasthenia gravis: Case series and literature review},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {2},
  doi = {10.1111/cns.14568}
}
Kostenlos starten →